InClinica Strengthens European Team
Nathan McCavery Joins InClinica as Director of Business Development
PHILADELPHIA (October 31, 2017) – InClinica, a global clinical CRO, announced that Nathan McCavery has been appointed Director of Business Development, based in the United Kingdom. McCavery will be responsible for engaging new clients, developing sales strategies and expanding market growth in the U.K. and Scandinavia regions.
Before joining InClinica, McCavery served as the Commercial Manager for BioKinetic Europe Limited where he managed all functions of business development, including the execution of marketing and sales strategies. He has a strong background in sales, scientific process and developing relationships.
“Nathan’s drive and ambition made him the obvious choice for this role,” said John Pearson, Vice President and General Manager, Europe. “His extensive knowledge and understanding of client relationships and ties within the clinical trial sector will be a valuable asset to our team.”
McCavery has an M.A. in Business Studies from The University of Edinburgh.
InClinica is a global clinical contract research organization founded in 2016 after the acquisition of an existing global CRO. With a senior management team that brings more than 100 combined years of experience, InClinica works across all phases of the clinical research process and has a particular strength in first in man and phase 2 studies. InClinica is headquartered in Philadelphia with other locations in the U.K., Israel, and Malaysia/Singapore.